effects of intra-ovarian injection of autologous platelet rich plasma
- Conditions
- diminished ovarian reserve.infertility due to diminished ovarian reserveN97.0
- Registration Number
- IRCT20101227005485N9
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 22
Antimullerian hormone(AMH) less than 1.1
number of antral follicles less than 5-7
history of cycle cancellation due to insufficient follicular growth
history of cycle cancellation due to less than 3 oocytes obtained
willingness to cooperate
Ages between 30 and 43 years
Immunoglobulin A deficiency
genital or non-genital cancers
treatment with anticoagulants
ovarian failure due to chromosomal abnormality
severe pelvic adhesion
non-acceptance or cooperation of the patient
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of oocytes obtained. Timepoint: Immediately after ovarian puncture before and 2 months after injection of platelet-rich plasma (PRP). Method of measurement: Under a microscope by an embryologist.;Follicular Stimulating Hormone (FSH) and Luteinizing Hormone (LH) day two or three of menstruation. Timepoint: Cycle before and 2 months after injection of platelet-rich plasma. Method of measurement: electrochemiluminescence.;Antimulerian hormone. Timepoint: Cycle before and 2 months after injection of platelet-rich plasma. Method of measurement: electrochemiluminescence.;Comparison of serum estradiol levels on the day of ovulation triggering. Timepoint: Cycle before and 2 months after injection of platelet-rich plasma. Method of measurement: electrochemiluminescence.
- Secondary Outcome Measures
Name Time Method umber of 4 to 8 cells embryos. Timepoint: 2 to 3 days. Method of measurement: With a microscope by an embryologist.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.